SITC

Title: A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab in checkpoint inhibitor refractory advanced or unresectable melanoma
Authors: Alexander N. Shoushtari, MD; Anthony J. Olszanski, MD, RPh; Thomas J. Hornyak, MD; Jedd D. Wolchok, MD, PhD; Sylvia Vetrhus; Karianne Risberg Handeland; Lukasz Kuryk, PhD; Magnus Jaderberg, MD;
Date: 9 November 2019
Time: 5:30 pm – 5:45 pm
Presenter: Dr. Alexander Shoushtari, Principal Investigator, MSKCC, NYC

 

Marlyland USA Add to Calendar

Upcoming events

Subscribe

Share